Olanow CW, Hauser RA, Burdick DJ, Dhall R, et al. A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease. Mov Disord 2023 Oct 27. doi: 10.1002/mds.29642.
PMID: 37886872